Genzyme sues Seikagaku on 5,399,351


Genzyme sues Seikagaku on US patent 5399351 (Expiry: 21/03/2012) for Seikagaku’s Hyaluronic acid product (Gel-One). We may recall that Genzyme has sued Q-med on the same patent ‘ 351 and later Q-med/Medicis settles the law suit with Genzyme (Link).

Genzyme markets some hyluronic acid based products like dermal fillers and Synvisc osteoarthritis product.

Seikagaku has recently received approval for Gel-One (cross-linked viscoelastic hyaluronate hydrogel).

Complaint details: [RFC Express] [Copy]

News: [Bizjournals] [Law 360]

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , . Bookmark the permalink.

One Response to Genzyme sues Seikagaku on 5,399,351

  1. Pingback: Genzyme Hyaluaronic acid products | PATENT DAILY

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s